EffPha – An expert-based CRO for your drug develop
廠商名稱:精睿醫藥科技股份有限公司
發佈日期:2026-06-30
攤位號碼:M1117
Efficient Pharma Management Corp. (EffPha) is a full-service CRO providing drug development services, including strategic and technical consulting, biostatistics, data management, regulatory dossier preparation and submission, and clinical study management and monitoring.
EffPha has established a team of experts with over 30 years of drug development experience from global pharmaceutical companies since founded. That EffPha is an expert-based CRO is the brand positioning by providing advice based on practical industry experience from domestic and international new drug development companies.
We knew an experienced and talented drug development team can not only provide decision-makers with the best strategies of drug development, advise and direct clinical operations, but also identify potential risks in drug development, which allows them to further plan risk management or adjust the direction of product development. Therefore, it would help shorten drug development timelines and mitigate risks for biotech and pharmaceutical companies, allocating development resources more efficiently.
EffPha excels at proposing the most suitable drug development strategies, designing clinical trials with high success rates, and providing high-quality clinical trial monitoring and management for the purpose of providing clients with the most efficient services. In recent years, clinical trials have tended to be conducted in multiple countries. In response, EffPha has set its sights on the global market. EffPha has taken the initiative to build a global presence, expand CRO services for international multi-center clinical trials, and move forward with our long-term collaborative pharmaceutical partners.
Visit us to learn how EffPha can help support your drug development projects at https://www.effpha.com/.
更多參展商新聞稿
- 無線感測器與資料記錄系統 確保環境穩定、符合法規並避免樣品與產品失效 幸託有限公司 / 2026-07-28
- 潤霈生技2026亞洲生技大展人氣爆棚 自有品牌明星產品強勢登場強力吸睛 潤霈生技股份有限公司 / 2026-07-22
- 2026 潤霈生技攜手圓安生技 全面導入PIF產業認證新布局 潤霈生技股份有限公司 / 2026-07-22
- 潤霈生技2025持續亮眼 取得新型專利證書 開啟2026強勁動能 潤霈生技股份有限公司 / 2026-07-22
- 微體生醫參加亞洲生技大展,推進日本PoC計劃並拓展東南亞布局 微體生物醫學股份有限公司 / 2026-07-22
- 比利時瓦隆尼亞連續三年參展亞洲生技大展 企業展現生技實力 比利時瓦隆尼亞外貿投資總署 / 2026-07-21
- 中山大學領軍南臺灣科研成果 亮相2026亞洲生技大展 國立中山大學 / 2026-07-18
- 精密電鑄微孔霧化模組、吸入式藥物傳遞霧化片 Product Specification 和淞科技股份有限公司 / 2026-07-16
- 和淞醫療級噴霧片 打造優質網式霧化裝置 和淞科技股份有限公司 / 2026-07-16
- 【和淞科技】幫台積電蓋廠還不夠!半導體老手攻醫材,家庭到加護病房都切入 和淞科技股份有限公司 / 2026-07-16
- 冷泉港生物科技 聚焦再生醫療GMP製程、精準醫療與實驗室優化 冷泉港生物科技股份有限公司 / 2026-07-16
- 銳準生醫攜手 Nanomics,首發AI 驅動次世代質譜蛋白體平台,探索超深度臨床生物標記 銳準生醫股份有限公司 / 2026-07-15
- 思捷優達-KY (7829) 攜挪威頂尖研究中心簽MOU 加入全球巴金森氏症平台臨床試驗HYDRA 英屬開曼群島商思捷優達股份有限公司 / 2026-07-15
- 思捷優達-KY (7829)多重系統退化症AI新藥二期順利 啟動國際授權腳步 英屬開曼群島商思捷優達股份有限公司 / 2026-07-15
- 微一生醫以光學級微結構成型技術串聯 Beauty 與 Biomedical Innovation 微一生醫股份有限公司 / 2026-07-15
- 中裕發起「為愛生根 (Rooting for Love)」公益活動攜手台灣露德協會溫暖守護愛滋社群 中裕新藥股份有限公司 / 2026-07-15
- AI時代下G2市場大功能食品合規之路 台灣健康產業協會7月16日南港舉辦中美市場法規研討會 台灣健康產業協會 / 2026-07-15
- 生技展逛到 PREMARKETING(N010) 駐站顧問幫您提供出產品出口可行性初判 台灣健康產業協會 / 2026-07-15
- 【展會預告】 有臨醫藥誠邀您共赴 2026 BIO Asia-Taiwan(亞洲生技大會) 上海有臨醫藥科技有限公司 / 2026-07-14
- MicroDoctor Cosmetics 驅動新世代保養科技,打造先進經皮傳導解決方案 微一生醫股份有限公司 / 2026-07-14